Business
WELL Health Announces Approval of Normal Course Issuer Bid
WELL Health Technologies Corp. (TSX: WELL) (OTCQX: WHTCF) (“ WELL ” or the ...
About this update from Well Health Technologies Corp.
[{"type":"text","content":"WELL Health Announces Approval of Normal Course Issuer Bid\n\n\n .bwalignc { text-align: center; list-style-position: inside }\n.bwuline { text-decoration: underline }\n \n\n\n\n WELL Health Technologies Corp. (TSX: WELL) (OTCQX: WHTCF) (“\n \n WELL\n \n ” or the “\n \n Company\n \n ”), a digital health company focused on positively impacting health outcomes by leveraging technology to empower healthcare practitioners and their patients globally, is pleased to announce that the Notice of Intention to Make a Normal Course Issuer Bid (“\n \n NCIB\n \n ”) it filed with the Toronto Stock Exchange (“\n \n TSX\n \n ”) has been approved. The NCIB is an early renewal of its NCIB that was set to expire on June 9, 2025 (the “\n \n 2024 NCIB\n \n ”).\n \n\n WELL believes that purchases of its common shares (the “\n \n Shares\n \n ”) pursuant to the NCIB may contribute to the facilitation of an orderly market and be in the best interests of the Company and its shareholders. In the event that WELL believes that its Shares begin trading in a price range that does not adequately reflect their underlying value based on WELL’s business prospects and financial position, WELL may purchase Shares pursuant to the NCIB. Depending upon future price movements and other factors, WELL believes that its outstanding Shares may represent an attractive investment and a desirable use of a portion of its corporate funds.\n \n\n As of May 7, 2025, the Company had 253,056,708 Shares issued and outstanding. Under the NCIB, the Company may acquire up to an aggregate of 6,326,417 Shares over the next 12-month period, representing approximately 2.5% of the issued and outstanding Shares of the Company. In accordance with TSX rules, daily purchases made by the Company on the TSX will not exceed 284,830 Shares, subject to certain prescribed exemptions, being 25% of the average daily trading volume over the preceding six calendar months of 1,139,321 Shares. The NCIB will be effective from May 20, 2025 to May 19, 2026. Purchases subject to this NCIB will be made on the open market through the facilities of the TSX and any Canadian alternative trading systems in Canada by a broker on behalf of the Company in accordance with applicable regulatory requirements. All Shares purchased un...